Australia's most trusted
source of pharma news
Monday, 16 February 2026
Biosimilars failed to steal market share from originator brands last financial year. Despite the number subsidised on the PBS soaring by 50 per cent, total Government spending on biosimilars grew by a measly 1.65 per cent.